1. Medtech Insight
  2. >>Business
  3. >>R&D
  4. >>Clinical Trials

Three Studies Support Medtronic’s Cryoablation Systems As ‘First Line’ AFib Treatment

 
• By Reed Miller

Data from the EARLY AF First, Cryo-FIRST and STOP AF trials show cryoablation is a better option than drugs for patients with symptomatic atrial fibrillation.

MEDTRONIC'S ARCTIC FRONT ADVANCE CRYOBALLOON • Source: Medtronic PLC

Results of three different trials showed pulmonary vein isolation ablation with Medtronic’s Arctic Front Advance cardiac cryoballoon is a safe and effective “first line” option for patients with atrial fibrillation, even if they have not already tried drug therapy.

The company hopes the results of these trials will lead the US Food and Drug Administration to expand the approved...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D

Sofinnova And NVIDIA Partner To ‘Supercharge’ Computation For European Startups

 
• By Natasha Barrow

European venture capital firm Sofinnova Partners’ portfolio companies BioCorteX, Bioptimus, Cure51 and Latent Labs will benefit from the investor’s new partnership with tech giant NVIDIA.

Somnee AI-Powered Sleep Wearable Raises $10M Seed Round

 
• By Natasha Barrow

The $10m seed extension funding round will be used to launch the second-generation wearable headband with the added SmartSleep AI operating system.

Ultrahuman Launches Home Health Monitoring

 
• By Natasha Barrow

Ultrahuman seeks to “create an environment that aligns with our bodies" by linking environmental parameters collected by Ultrahuman Home to health physiology, measured by the Ultrahuman Ring Air.